Fresenius Medical Care closes at $23.65 after gaining 0.85%

A quick look at today: bullish sentiment helped the US-German healthcare company to hammer out a noteworthy $23.32 to $23.69 range today, and finally closing at $23.65 to end the session.

Fresenius Medical Care is currently trading at $23.65 following the release of Fed Chair Powell testimony data from the United States.

Meanwhile, United States Building Permits (May) released yesterday at 12:30 UTC with a figure of 1.49 million, while the previous figure was 1.15 million. United States API Weekly Crude Oil Stock came out at -1.25 million, while a consensus of analysts was expecting -433,000. Fresh 20-Year Bond Auction data from United States came out at 4.01.

Despite posting gains on today, Fresenius Medical Care AG & Co. KGaA slid below its 5 day Simple Moving Average at $23.36 during the last session — an early indicator that a negative trend could be emerging. Fresenius Medical Care's upper Bollinger Band® is at $24.06, this is a slight indication of a slowdown. In contrast, Fresenius Medical Care broke through the $23.54 resistance, climbing 11 cents above it.

Technical analysis suggests there could be an imminent reversal for Fresenius Medical Care.

This rally in Fresenius Medical Care's share price coincided with other health care stocks as UnitedHealth traded at $476.75 after closing today's trading day at $469.39 (up 1.57%). Sanofi was up 1.02%.

Fresenius Medical Care went up today, yet these health care stocks did not follow — Pfizer closed at $38.9 (down 1.12%).

Today's gains have given market bulls further impetus to expect strong macro data going forward, such as United States Initial Jobless Claims is projected to outperform its last figure with 260,000. It previously stood at 262,000; data will be released tomorrow at 12:30 UTC.

Furthermore, the market is looking at United States Crude Oil Inventories projected to come out at 1.87 million — worse than previous data of 7.92 million; data will be released tomorrow at 15:00 UTC.

The market is looking forward to the release of new data: United States Existing Home Sales (May) is scheduled for tomorrow at 14:00 UTC.

The past 3 months have been positive for the kidney dialysis specialist as it added 20.63% compared to its 3-month low of $12.81.